NEW YORK, Oct. 25, 2024 /PRNewswire/ — Report with the AI impact on market trends – The Global Interventional Radiology Products Market size is estimated to grow by USD 5.45 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 7.1% during the forecast period. Growing demand for minimally invasive surgical procedures is driving market growth, with a trend towards launch of new interventional radiology products. However, shortage of radiologists poses a challenge.Key market players include Abbott Laboratories, Adept Medical Ltd., ASAHI INTECC CO. LTD., B. Braun Interventional Systems Inc., Blueneem Medical Devices Pvt. Ltd., Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., GE Healthcare Technologies Inc., Guerbet, ILUMARK GmbH, INRAD Inc., Koninklijke Philips N.V., Merit Medical Systems Inc., Seda SpA, Siemens Healthineers AG, Teleflex Inc., Terumo Corp., Tokai Medical Products Inc., and Uresil LLC.
Technavio has announced its latest market research report titled Global Interventional Radiology Products Market 2024-2028
AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now
|
Forecast period |
2024-2028 |
|
Base Year |
2023 |
|
Historic Data |
2018 – 2022 |
|
Segment Covered |
Type (Stents, Catheters, Embolization devices, Inferior vena cava filters, and Others), Application (Cardiology, Urology and nephrology, Oncology, Gastroenterology, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)) |
|
Region Covered |
North America, Europe, Asia, and Rest of World (ROW) |
|
Key companies profiled |
Abbott Laboratories, Adept Medical Ltd., ASAHI INTECC CO. LTD., B. Braun Interventional Systems Inc., Blueneem Medical Devices Pvt. Ltd., Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., GE Healthcare Technologies Inc., Guerbet, ILUMARK GmbH, INRAD Inc., Koninklijke Philips N.V., Merit Medical Systems Inc., Seda SpA, Siemens Healthineers AG, Teleflex Inc., Terumo Corp., Tokai Medical Products Inc., and Uresil LLC |
Key Market Trends Fueling Growth
Interventional radiology products are used to treat various medical conditions through minimally invasive procedures, utilizing image-guiding technologies. These conditions span vascular diseases, cancer care, and common health issues affecting men and women. Vendors are intensifying research and development to introduce advanced interventional radiology products and upgrade existing systems. In June 2024, B. Braun Interventional Systems launched new ACCEL All-Purpose and Biliary Drainage Catheters with TrueGlide Hydrophilic Coating for percutaneous drainage. Cook Group Inc. Announced the availability of its Slip-Cath Beacon Tip hydrophilic selective catheter in the US and Canada in January 2024. These product innovations will boost the demand for advanced interventional radiology procedures and fuel market growth during the forecast period.
Interventional Radiology (IR) products play a crucial role in treating chronic diseases like cancer and cardiovascular problems. IR uses minimally invasive procedures, such as CT scans, MRIs, and ultrasounds, for accurate diagnosis. Advanced IR products include smart inhalers, IVC filters, stents, catheters, thrombectomy systems, angioplasty balloons, and biopsy needles. These devices are used in various medical fields like cardiology, oncology, gastroenterology, neurology, orthopedics, and urology. IR products are used in hospitals, clinics, and home care settings. With the rise in chronic diseases, the demand for IR products is increasing. Advanced therapeutics, such as IVC filters and thrombectomy systems, help reduce healthcare costs by minimizing hospital stays. Medical devices and digital health technologies are transforming IR, making procedures more efficient and effective. Healthcare insurance systems cover most IR procedures, making them accessible to a larger population.
Insights on how AI is driving innovation, efficiency, and market growth- Request Sample!
Market Challenges
The radiology workforce crisis is a pressing issue in the healthcare industry, with the number of radiologists failing to keep up with the increasing demand for radiology services. In the US and India, for instance, the aging population and the rising prevalence of chronic diseases have driven in demand for radiology services. However, the number of radiologists graduating from training programs has not matched this trend. The expanding scope of radiology, fueled by advancements in medical imaging technology, has led to an increased volume of diagnostic and interventional procedures. This heightened need for skilled radiologists to interpret complex imaging studies and perform minimally invasive treatments is not being met. By 2028, the radiologist shortage is projected to rise from 30% to 40%. This shortage has significant implications for the healthcare industry. Longer wait times for patients requiring imaging services can potentially delay diagnoses and treatments, impacting patient outcomes. Overburdening existing radiologists can lead to burnout and reduced job satisfaction, further worsening the staffing crisis. Moreover, maintaining the quality of care becomes a challenge as the workforce becomes increasingly strained. Overburdening the existing workforce can impact the accuracy and efficiency of imaging interpretations, negatively impacting interventional radiology procedures and, ultimately, the growth of the interventional radiology products market during the forecast period.
Interventional Radiology Products Market: Overcoming Challenges in Chronic Disease Management The Interventional Radiology Products market faces numerous challenges in catering to the growing demand for minimally invasive procedures in various medical specialties. These include Cardiology, Oncology, Gastroenterology, Neurology, Orthopedics, and Urology. Key products like Embolization devices, Thrombectomy systems, Angioplasty balloons, and Biopsy needles play a crucial role in treating chronic diseases such as Cardiac diseases, Inferior Vena Cava (IVC) filters, and Angioplasty procedures. Market expansion includes addressing challenges in Hospitals, Clinics, and Home care settings. Healthcare Insurance Systems, Medical devices, and Digital health technologies like remote patient monitoring and preventive care are crucial for managing chronic conditions. Advanced therapeutics, Genomics, Molecular diagnostics, and Personalized medicine are transforming treatment procedures. Cybersecurity threats and patient data safety are critical concerns. Healthcare professionals require adequate training and resources to effectively use these products. Rising healthcare expenditures, medical insurance coverage, medical tourism, and private healthcare also impact market growth. Urology and Nephrology, Treatment Procedures, and Cybersecurity threats are some of the current challenges. Collaboration between stakeholders, regulatory compliance, and continuous innovation are essential for market success.
Insights into how AI is reshaping industries and driving growth- Download a Sample Report
Segment Overview
This interventional radiology products market report extensively covers market segmentation by
Type
1.1 Stents
1.2 Catheters
1.3 Embolization devices
1.4 Inferior vena cava filters
1.5 Others
Application
2.1 Cardiology
2.2 Urology and nephrology
2.3 Oncology
2.4 Gastroenterology
2.5 Others
Geography
3.1 North America
3.2 Europe
3.3 Asia
3.4 Rest of World (ROW)
1.1 Stents- Interventional radiology stents are essential medical devices used to treat various vascular conditions, including coronary artery disease and peripheral artery disease. Boston Scientific Corp. And other market players invest in research and development to enhance stent efficacy, safety, and compatibility with patient anatomy. In coronary artery disease, stents maintain arterial openness post-angioplasty, ensuring improved heart blood flow. Stents also address peripheral artery disease, restoring proper limb blood flow and reducing pain. For aneurysms, stents reinforce weakened arterial sections, preventing rupture and potential life-threatening complications. In venous diseases like deep vein thrombosis, stents keep veins open, reducing the risk of pulmonary embolism. Boston Scientific Corp.’s focus on improving stent technology will fuel market growth, ensuring optimal patient care and outcomes during the forecast period.
Download complimentary Sample Report to gain insights into AI’s impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 – 2022)
Research Analysis
Interventional radiology is a subspecialty of radiology that uses minimally invasive techniques and image-guided procedures to diagnose and treat various chronic diseases, including cancer and cardiovascular problems. Interventional radiology products play a crucial role in this field, offering advanced therapeutics such as stents, catheters, and angioplasty balloons for the treatment of IVC filters, aneurysms, and other conditions. Imaging technologies like CT scans, MRIs, and ultrasounds are essential for accurate diagnosis, while smart inhalers and digital health technologies enable remote patient monitoring and preventive care. Advanced interventional radiology products include thrombectomy systems, embolization devices, and biopsy needles, which are used in the treatment of cardiovascular diseases and cancer. The integration of genomics, molecular diagnostics, and personalized medicine into interventional radiology is revolutionizing the way chronic conditions are diagnosed and treated, leading to improved patient outcomes and reduced healthcare costs.
Market Research Overview
Interventional radiology is a subspecialty of radiology that uses minimally invasive techniques and advanced therapeutic procedures to treat various chronic diseases, including cancer and cardiovascular problems. Interventional radiology products play a crucial role in this field, enabling the use of imaging technologies such as CT scans, MRIs, and ultrasounds to guide the placement of devices like stents, catheters, IVC filters, embolization devices, thrombectomy systems, angioplasty balloons, and biopsy needles. These products are used in various medical fields, including cardiology, oncology, gastroenterology, neurology, orthopedics, and urology, in hospitals, clinics, home care settings, and other healthcare facilities. The use of advanced therapeutics, digital health technologies, remote patient monitoring, and preventive care is driving the growth of the interventional radiology products market. Chronic conditions, such as cardiovascular diseases and cancer, are major drivers of healthcare costs, and interventional radiology offers cost-effective solutions through minimally invasive procedures. However, concerns around healthcare insurance systems, medical tourism, and private healthcare, as well as cybersecurity threats and patient data safety, are challenges that the market must address. The use of genomics, molecular diagnostics, and personalized medicine is also transforming the interventional radiology landscape, enabling individualized treatment plans for patients.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
Type
Stents
Catheters
Embolization Devices
Inferior Vena Cava Filters
Others
Application
Cardiology
Urology And Nephrology
Oncology
Gastroenterology
Others
Geography
North America
Europe
Asia
Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+Newsrooms &Influencers
9k+Digital MediaOutlets
270k+JournalistsOpted In